107
Views
25
CrossRef citations to date
0
Altmetric
Original Research

FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition

, , , , , , , , , , & show all
Pages 1653-1665 | Published online: 19 Feb 2019

References

  • BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalAGlobal cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA Cancer J Clin201868639442430207593
  • EndoTYoshikawaMEbaraMImmunohistochemical metallo-thionein expression in hepatocellular carcinoma: relation to tumor progression and chemoresistance to platinum agentsJ Gastroenterol200439121196120115622485
  • NietoMAHuangRYJacksonRAThieryJPEmt: 2016Cell20161661214527368099
  • DongreARashidianMReinhardtFEpithelial-to-mesenchymal transition contributes to immunosuppression in breast carcinomasCancer Res201777153982398928428275
  • KaraosmanoğluOBanerjeeSSivasHIdentification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cellsCell Oncol2018414439453
  • ChuaHLBhat-NakshatriPClareSEMorimiyaABadveSNakshatriHNF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2Oncogene200726571172416862183
  • CajaLKahataKMoustakasAContext-dependent action of transforming growth factor β family members on normal and cancer stem cellsCurr Pharm Des201218274072408622630079
  • YangMHChenCLChauGYComprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinomaHepatology20095051464147419821482
  • MosessonMWFibrinogen and fibrin structure and functionsJ Thromb Haemost2005381894190416102057
  • DuanSGongBWangPHuangHLuoLLiuFNovel prognostic bio-markers of gastric cancer based on gene expression microarray: COL12A1, GSTA3, FGA and FGGMol Med Rep20181843727373630106150
  • LymanGHKhoranaAACancerKAACancer, clots and consensus: new understanding of an old problemJ Clin Oncol200927294821482619752337
  • NiuJYTianTZhuHYHyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphomaAnn Hematol201897101841184929860562
  • HuangWWangSZhangHZhangBWangCPrognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancerCancer Biol Med2018151889629545972
  • ShioseSHataYNodaYFibrinogen stimulates in vitro angiogenesis by choroidal endothelial cells via autocrine VEGFGraefes Arch Clin Exp Ophthalmol2004242977778315103470
  • AdamsGNRosenfeldtLFrederickMColon cancer growth and dissemination relies upon thrombin, stromal PAR-1, and fibrinogenCancer Res201575194235424326238780
  • GaoHJChenYJZuoDQuantitative proteomic analysis for high-throughput screening of differential glycoproteins in hepatocellular carcinoma serumCancer Biol Med201512324625426487969
  • DavalievaKKiprijanovskaSMaleva KostovskaIComparative proteomics analysis of urine reveals down-regulation of acute phase response signaling and LXR/RXR activation pathways in prostate cancerProteomes2017611
  • ChenJYChenWNLiuLLHepatitis B spliced protein (HBSP) generated by a spliced hepatitis B virus RNA participates in abnormality of fibrin formation and functions by binding to fibrinogen γ chainJ Med Virol201082122019202620981788
  • YokoyamaKEricksonHPIkedaYTakadaYIdentification of amino acid sequences in fibrinogen gamma -chain and tenascin C C-terminal domains critical for binding to integrin alpha vbeta 3J Biol Chem200027522168911689810747940
  • YokoyamaKZhangXPMedvedLTakadaYSpecific binding of integrin alpha v beta 3 to the fibrinogen gamma and alpha E chain C-terminal domainsBiochemistry199938185872587710231539
  • NagataKAraiSTairaCSuganoMHondaTOkumuraNA novel frameshift mutation in the fibrinogen γC terminal region, FGG c.1169_1170 del AT, leading to hypofibrinogenemiaThromb Res2017159828528992465
  • WangYLiuHLiangDReveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomicsJ Proteomics201715023024127693406
  • CaiZZengYXuBGalectin-4 serves as a prognostic biomarker for the early recurrence/metastasis of hepatocellular carcinomaCancer Sci2014105111510151725230111
  • SongDGYeQCarpenitoCIn vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB)Cancer Res201171134617462721546571
  • ZhaoBZhaoWWangYConnexin32 regulates hepatoma cell metastasis and proliferation via the p53 and Akt pathwaysOncotarget2015612101161013325426556
  • ZhuWLFanBLLiuDLZhuWXAbnormal expression of fibrinogen gamma (FGG) and plasma level of fibrinogen in patients with hepatocellular carcinomaAnticancer Res20092972531253419596924
  • WeiselJWLitvinovRIFibrin formation, structure and propertiesSubcell Biochem20178240545628101869
  • BrabletzTJungASpadernaSHlubekFKirchnerTOpinion: migrating cancer stem cells – an integrated concept of malignant tumour progressionNat Rev Cancer20055974474916148886
  • LamouilleSXuJDerynckRMolecular mechanisms of epithelial-mesenchymal transitionNat Rev Mol Cell Biol201415317819624556840
  • ZhangPSunYMaLZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistanceCell Cycle201514448148725607528
  • XiaLHuangWTianDOverexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinomaHepatology201357261062422911555
  • PeinadoHOlmedaDCanoASnailCASnail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?Nat Rev Cancer20077641542817508028
  • HondaKIAsadaRKageyamaKProtein complex of fibrinogen gamma chain and complement factor H in ovarian cancer patient plasmaAnticancer Res20173762861286628551622
  • SchneiderGBryndzaEPoniewierska-BaranAEvidence that vitronectin is a potent migration-enhancing factor for cancer cells chaperoned by fibrinogen: a novel view of the metastasis of cancer cells to low-fibrinogen lymphatics and body cavitiesOncotarget2016743698296984327634880